 OUTLINE: This is a randomized, multicenter study. Patients are stratified according to tumor size 2-4 cm vs 4 cm, nodal status negative vs positive, hormone receptor status estrogen receptor ER-positive andor progesterone-receptor PgR-positive vs ER- and PgR-negative, and age 50 years vs 50 years. Patients are randomized to 1 of 6 treatment arms. 